There was no evidence of association between this variant and breast cancer risk in BRCA1 mutation carriers or between the same variant and ovarian cancer risk in either BRCA1 or BRCA2 mutation carriers (p > 0.30). The gene discussed is BRCA1; the disease is ovarian carcinoma.